Human immunodeficiency virus (HIV) Infections and Infestations Human immunodeficiency virus (HIV)
Conditions
Interventions
Both arms will receive mobile telephones. However in the control arm, there will be no further interaction via the mobile phone. In the intervention arm, the mobile phone intervention will be as descr
Sponsors
European Union (EU) (Belgium)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Human immunodeficiency virus (HIV) seropositive 2. Aged between 18 - 60 years, either sex 3. Meet criteria to start ART (in India, ART is indicated for symptomatic patients with a World Health Organization [WHO] Clinical Stage 4 condition regardless of CD4 counts and plasma viral load; WHO Stage 3 condition with CD4 less than 350/mm^3 and in asymptomatic patients, with CD4 count less than 200/mm^3) 4. ART naive (i.e. no prior antiretroviral therapy or ART for less than 7 days) 5. Residence in the Southern Indian States with the ability to visit clinic regularly for follow-up visits
Exclusion criteria
Exclusion criteria: 1. Severely ill (Karnofsky score less than 70) at the time of recruitment 2. Impaired renal function (creatinine greater than 2 times upper limit of normal) 3. Study participant already recruited in the same household 4. Non-availability of mobile telephone network
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to occurrence of virological failure (defined as having greater than 400 copies/ml on two consecutive measures at least one month apart. Date of failure is documented as the date of initial reading of the value greater than 400 copies/ml. | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-reported adherence expressed as a percentage | — |
Countries
India
Outcome results
None listed